It is unclear whether these splenic CD8+ T cells are recent emigrants from the tumor or tumor‐draining LN where priming likely occurs,27 or whether the pro‐inflammatory conditions generated in the spleen upon CD47 × PD‐L1 BisAb treatment may augment the activation of these cells.16 The gene discussed is CD47; the disease is neoplasm.